Future Medical Outlook

Absrtact: I. Future medical Outlook medical care will no longer be limited to clinics or hospitals, and the family will be the main place for medical care. Professional medical care will be reserved for serious injuries and emergencies. Conventional medical institutions are mainly aimed at general surgery, while chronic diseases of the Tube

Future Medical Outlook

Medical care will no longer be confined to clinics or hospitals, and families will be the main place for medical care. Professional medical care will be reserved for serious injuries and emergencies. Conventional medical institutions are mainly aimed at general surgery, and the management of chronic diseases will be entrusted to community health care. Health care for a particular patient group is provided by the insurance Agency, which is mainly divided by population risk. New funding options include annual insurance costs, collective insurance budgets, individual equity or personal health budgets.

-A wide range of wireless devices can be networked to connect patients with health care personnel through video, and expenses can be reimbursed.

-The productivity of the medical profession has been greatly improved, including reduced transit and waiting times, routine communication and tele-interrogation that make it easier to see a doctor, and electronic diagnostic tools that help doctors with remote check-ups.

-Automated surgery and automated assisted surgery are common. The automated operating platform allows for more detailed image details while helping physicians visualize the entire procedure through 3D glasses.

-The use of new technologies: for example, 3D printing of medical equipment and organs, through the esophagus for non-invasive surgery rather than skin, through brain cell transplants to help patients with heart failure, stroke and paralysis.

Corresponding breakthrough

-Remote Assistance, field doctors can help guide the operation of the on-site doctor or robot, the program has been approved by the relevant departments and doctors support.

-There will be a sharp decline in the number of denial of access to telemedicine, and authorities and insurers have made clear that technology is safe and efficient, and that new tools will help doctors deal with large amounts of data.

-The new insurance scheme allows specific patients to receive full reimbursement for medical treatment at designated institutions.

-Allow patients to have a strong sense of their health data and enter a patient-centred, income-based, new, patient pairing model.

-health programmes designed around patients can simplify the allocation of resources for hospital and community health care. Professional doctors and nurses to provide professional medical services for the whole society, primary care staff for the community and specialist hospitals to provide timely and convenient basic health care services.

Ii. Wearable Equipment

Wearable devices are now part of the measure of the quality of consumer life and are used to collect, track and manage consumer health. Consumers and medical institutions seamlessly connect health data through a variety of terminals to better understand their physical condition. The ubiquitous wearable devices are no longer exclusive to enthusiasts, and special devices with biological sensing capabilities are also more affordable. The new doctor-patient relationship is based on the promotion of health awareness, the self-management of data and prevention, and replaces the once paternalistic approach to care.

-Wearable equipment ushered in a major outbreak, widely recommended and used extensively, as a part of people's prevention of disease and healthy life.

-A new generation of wearable equipment that can support multiple people to use, have a better interactive experience, more beautiful, more accurate results. New technologies make prices cheaper, but more functions and more accurate data.

-Wearable devices continually test the body's data, covering all activities from the body to the brain.

-Biosensor will analyze and compare the data collected by various equipment, and can contrast the analysis results with medical literature records.

-Extensive use of wearable equipment in clinical trials not only improves efficiency and safety, but also tracks the quality of patients ' lives.

-Wearable devices are part of the treatment regimen-helping to manage patient data while also effectively controlling treatment costs.

-Wearable equipment has made the family an extension of the hospital, and patients who have received treatment can be discharged quickly.

-Patients ' comments and feedback on Health applications form the basis of industry standards for health application design.

-Biosensors are still an emerging sector relative to emerging healthcare companies, and the new industry is nurturing new winners.

Corresponding breakthrough

-The convenience of data collection, the accuracy of medical data and the interoperability of data collection equipment and analysis tools are addressed.

-There are specific clinical criteria for measuring the quality of life.

-While privacy is still a problem, effective government management and good corporate reputation allow patients to disclose their health data, whether they are recorded by equipment or medical data.

-Patients know how to link different data in different ways, and if they are sure that their medical information is correct, they can upload their data to existing standard online medical records.

-Patient involvement in the management of medical data can give better assurance of the continued management of chronic diseases and a clearer return on investment (ROI) for healthcare providers.

Iii. Large Data

In many countries, health-care data has become an important part of the country's public service, with huge amounts of money (similar to the construction of the US Highway around 1950). At present, patients, health care workers, health departments use these data to improve diagnosis and treatment, improve the productivity of the medical industry. Drug companies are working with patients and health systems to develop better drugs through data mining so that they can be put into the market more quickly and guide pricing based on actual results.

-Health systems recognize the value of existing and new data (such as electronic medical records, patient-supplied data) and promulgate management methods for data acquisition and data sharing, establish a cooperative platform for data analysis and change the way medical care is based on the results of data analysis.

– The use of health data as a new indicator of national economic development.

-Pharmaceutical companies are also absorbing a variety of partners (payment systems, hospital systems) to maximize the use of large data in the entire value chain of research and pricing, while enhancing their data value (data management, analytics) by attracting data from a variety of ways. The role of data has gone far beyond the boundaries of traditional research, product development and commercial use.

-New data-driven market competitors have disrupted traditional research and development barriers, focusing on data and final output, which are quite different from the way they have focused on research in the past.

-Genetic testing is considered feasible.

Corresponding breakthrough

-Public awareness of the benefits of rational use of personal health data.

-The country's massive investment in it and health data infrastructures makes data access easier, while protecting the privacy of user data and standardizing the use of user data.

-A constantly improved regulatory environment and high-quality user data (collected from fitness tracking devices and real-time monitoring devices) give consumers more say and help reassure consumers about how others can use their data.

-Medical staff can access patient data in real time and use analysis tools to compare data to help diagnose daily.

-Pharmaceutical companies have become more trusted partners throughout the health system, with records of successful collaborations in areas such as diagnostics, data analysis, private and public health services.

-Pharmaceutical companies have found ways to handle their data to avoid the inconvenience caused by imperfect health systems.

To be Continued ...